🔎 Trials Near Me

Home › Arrhythmia › Minnesota › Rochester

Arrhythmia clinical trials in Rochester, MN

7 studies for Arrhythmia are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

Recruiting
  • Mayo Clinic, Rochester
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07118358

Feasibility and Usability of a Chest-Strap Ambulatory ECG Monitor in Active Individuals in Comparison With a Traditional Ambulatory ECG Patch Monitor (MoMe ARC)

RecruitingObservational study
  • Mayo Clinic Rochester, Rochester
Ages 22 and older · All sexes · Updated Sep 17, 2026 · NCT07772817

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

RecruitingObservational study
  • Rochester, Rochester
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180

Evaluation of A Clinical Diagnostic Test for CRDS

Recruiting
  • Mayo Clinic, Rochester
All ages · All sexes · Updated Jul 22, 2026 · NCT06188689

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation

Recruiting
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT04685317

Mayo AVC Registry and Biobank

RecruitingObservational studyHealthy volunteers welcome
  • Mayo Clinic, Rochester
All ages · All sexes · Updated Apr 27, 2026 · NCT03049254

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

RecruitingObservational study
  • Mayo Clinic-Rochester, Rochester
Ages 18 to 100 · All sexes · Updated Dec 16, 2025 · NCT06039176

About Arrhythmia

Arrhythmia, also called irregular heartbeat comes in different types. The most common is atrial fibrillation. Read about symptoms and treatment.

More about Arrhythmia on MedlinePlus

Arrhythmia trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.